<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04932668</url>
  </required_header>
  <id_info>
    <org_study_id>2020427-8560</org_study_id>
    <nct_id>NCT04932668</nct_id>
  </id_info>
  <brief_title>Home Based Electrical Stimulation on Post-stroke Lower Limb Tightness.</brief_title>
  <official_title>The Feasibility and Impact of A Home-Based NMES Program on Post-Stroke Lower Limb Spasticity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Malaya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Malaya</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spasticity is a common complication post stroke. Post-stroke spasticity along with weakness&#xD;
      and lack of coordination result in gait abnormalities and functional limitations. Recent&#xD;
      treatment option include neuromuscular electric stimulation (NMES), a form of therapy that&#xD;
      applies electrical currents to produce contraction of innervated muscle by depolarizing local&#xD;
      motor nerves. Currently, there are wide varieties of NMES devices available commercially for&#xD;
      consumer.&#xD;
&#xD;
      The main purpose of this study is to evaluate the feasibility and acceptability of a&#xD;
      home-based NMES program on lower limb spasticity in patient with post-stroke more than 6&#xD;
      months and to assess the impact of the program. This is single arm prospective intervention&#xD;
      study. Patient will apply home-based NMES on their leg for 20 minutes, 5 days a week for 4&#xD;
      weeks. At the end of the study, an outcome measures will be assessed and patient will be&#xD;
      required to answer a questionnaires on their experience.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2020</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>To evaluate the feasibility and acceptability of a home-based NMES program on lower limb spasticity in patient with post-stroke</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retention Rate</measure>
    <time_frame>4 weeks</time_frame>
    <description>The proportion of patients who completed the program. Patient completed divided with patient recruited, expressed in percentage (%).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability</measure>
    <time_frame>4 weeks</time_frame>
    <description>Acceptability as evaluated at the end of the intervention by brief structured questionnaire developed for this study using 5 point Likert scale with 1 (strongly agree) and 5 (strongly agree).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical measurement of spasticity</measure>
    <time_frame>4 weeks (pre and post assessment)</time_frame>
    <description>Ankle dorsiflexor (gastroc) Modified Ashworth Scale (MAS) as measured in MAS grade 1, 1+, 2, 3, 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical measurement of spasticity</measure>
    <time_frame>4 weeks (pre and post assessment)</time_frame>
    <description>Modified Tardieu Scale (R1 and R2 angle of ankle dorsiflexion)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ankle dorsiflexion muscle strength</measure>
    <time_frame>4 weeks (pre and post assessment)</time_frame>
    <description>Manual Muscle Testing as measured in 0-5 (with 0 no movement and 5 is the strongest)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Outcome</measure>
    <time_frame>4 weeks (pre and post assessment)</time_frame>
    <description>10 meter walking test</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Spasticity as Sequela of Stroke</condition>
  <arm_group>
    <arm_group_label>Home-based Electrical Stimulation Program for lower limb spasticity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single arm prospective intervention study to assess the feasibility and impact of a home-based program. Patient will apply home-based NMES on their leg for 20 minutes, 5 days a week for 4 weeks. At the end of the study, an outcome measures will be assessed and patient will be required to answer a questionnaires on their experience.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Feasibility and Impact of Home-based Electrical Stimulation Program</intervention_name>
    <description>Home-based NMES program on spastic leg. The NMES pre-programmed dosage (locked):&#xD;
NMES waveform is biphasic PC, Frequency 50Hz, pulse width 400Âµs, ON:OFF 10s:20s and current amplitude: individual maximum tolerated to achieve ankle dorsiflexion.</description>
    <arm_group_label>Home-based Electrical Stimulation Program for lower limb spasticity</arm_group_label>
    <other_name>Program</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Post stroke (hemorrhagic or ischemic) with ankle plantarflexor (gastrocnemius and&#xD;
             soleus) spasticity MAS 1+ to MAS 3,&#xD;
&#xD;
          2. Post stroke more than 6 months,&#xD;
&#xD;
          3. At least 18 years old,&#xD;
&#xD;
          4. Able to ambulate 10 meter either independently or aided (single point stick or&#xD;
             quadripod)&#xD;
&#xD;
          5. Compliant to outpatient therapy.&#xD;
&#xD;
          6. Minimal cognitive (MMSE&gt; 24) and minimal sensory impairment,&#xD;
&#xD;
          7. Stable neurological and medical condition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Introduction or changes in anti-spastic medication dose within 3 months or during&#xD;
             study period,&#xD;
&#xD;
          2. Receiving intervention for spasticity (eg BoNT or serial casting) within 3 months or&#xD;
             during research period,&#xD;
&#xD;
          3. New neurological condition/disease,&#xD;
&#xD;
          4. Presence of contraindications to NMES, which is: Pregnancy, Malignancy, Presence of&#xD;
             electronic implant eg cardiac pacemaker, cardioverter defibrillator, Uncontrolled&#xD;
             seizure/epilepsy, Infected tissues/ tuberculosis or osteomyelitis, Impaired lower limb&#xD;
             circulation/ DVT/ thrombophlebitis, Recent fracture or osteoporosis, Actively bleeding&#xD;
             tissue or person with untreated hemorrhagic disorder, Damaged or skin diseases at the&#xD;
             affected lower limb&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raja Nabila BT Raja Mohamed Anuar</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Malaya Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tze Yang Chung</last_name>
    <phone>+60192226593</phone>
    <email>chungty@ummc.edu.my</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Malaya Medical Center</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tze Yang Chung</last_name>
      <phone>+60192226593</phone>
      <email>chungty@ummc.edu.my</email>
    </contact>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 6, 2021</study_first_submitted>
  <study_first_submitted_qc>June 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>June 12, 2021</last_update_submitted>
  <last_update_submitted_qc>June 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Malaya</investigator_affiliation>
    <investigator_full_name>Raja Nabila binti Raja Mohamed Anuar</investigator_full_name>
    <investigator_title>Doctor, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT04932668/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT04932668/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

